BGI Genomics is one of the world’s largest DNA sequencing service providers.
BGI Genomics, founded in August, 2008 and headquartered in Shenzhen, is a genomics R&D institution. The founder is Wang Jian. Listed on the SZSE on July 14, 2017, the company's major shareholders are BGI Genomics Co.,Ltd., Shenzhen Qianhai BGI Investment Enterprise (LP) and Shenzhen Heyu Gaolin Equity Investment Partnership (LP). Rivals that have direct and indirect competition with BGI Genomics include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.
ResearchHealthcare, Technology, Consumer Staples
WIA2020 | Rising Tech Stars 2020: Global & China's 100
ResearchReal Estate, Industrials, Financials
Tech for Global, Globalization Footprints of the Established and the New
Open Source, Open Mind: Baidu and LinkingMed Help Doctors in Medical Images
A Chinese startup, based on Baidu’s deep-learning open-source platform PaddlePaddle, is providing CT screening service to a Hunan-based hospital, hoping to facilitate the diagnosis process.
Mar 05, 2020 11:41 AM